Xcell Biosciences' Series A Round

Xcell Biosciences raised a round of funding on February 16, 2017. Investors include HBM Genomics.

Xcell Biosciences develops products and workflows that empower scientists in important fields including cancer research, immunology, stem cell biology, and cell therapy development. The company's adva…

Articles about Xcell Biosciences' Series A Round: